Isolated ocular metastases from lung cancer
Accepted for publication April 4, 2016
Correspondence Sonia Varghese, MD; sonia.varghese@mercy.net
Disclosures The authors report no disclosures/conflicts of interest.
Citation JCSO 2018;16(1):e106-e109
©2018 Frontline Medical Communications
doi https://doi.org/10.12788/jcso.0258
Submit a paper here
Conclusion
The goal of therapy in metastatic lung cancer is palliation of symptoms and improvement in patient quality of life with prolongation in overall survival. The newer targeted chemotherapeutic agents assist in achieving these goals and may decrease the morbidity associated from radiation or surgery with improvement in vision and regression of ocular metastatic lesions. Targeted therapies should be considered in the treatment of patients with ocular metastases from NSCLC.
,false
